Phenotypic and Genotypic Methods for detection of Biofilm

producing Coagulase Negative Staphylococci in a Tertiary Care Hospital. by Thilakavathy, P
PHENOTYPIC AND GENOTYPIC METHODS FOR 
DETECTION OF BIOFILM PRODUCING 
COAGULASE NEGATIVE STAPHYLOCOCCI 
IN A TERTIARY CARE HOSPITAL 
 
 
DISSERTATION SUBMITTED FOR 
BRANCH –IV – M.D. DEGREE 
(MICROBIOLOGY) 
APRIL 2013 
 
 
 
THE TAMILNADU 
DR.M.G.R. MEDICAL UNIVERSITY 
CHENNAI, TAMILNADU 
 BONAFIDE CERTIFICATE 
   
This is to certify that the dissertation entitled “PHENOTYPIC AND 
GENOTYPIC METHODS FOR DETECTION OF BIOFILM 
PRODUCING COAGULASE NEGATIVE STAPHYLOCOCCI IN A 
TERTIARY CARE HOSPITAL’’ submitted by Dr.P.THILAKAVATHY to 
the Tamil Nadu Dr.M.G.R. Medical University, Chennai in partial fulfillment 
of the requirement for the award of M.D degree Branch – IV ( Microbiology ) 
is a bonafide research work carried out by her under direct supervision and 
guidance. 
 
 
 
                                                                                      Director, 
                                                                                  Institute of Microbiology, 
                                                                                   Madurai Medical College, 
                                                                                      Madurai. 
 
 
 
 
 
 
 DECLARATION 
   
  I, Dr.P.THILAKAVATHY declare that, I carried out this work on 
“PHENOTYPIC AND GENOTYPIC METHODS FOR DETECTION OF  
BIOFILM PRODUCING COAGULASE NEGATIVE 
STAPHYLOCOCCI IN  A TERTIARY CARE HOSPITAL’’  at the 
Institute of Microbiology, Madurai Medical college. I also declare that this 
bonafide work or a part of this work was not submitted by me or any others for 
any award, degree or diploma to any other University, Board, either in India or 
abroad. 
 This is submitted to The Tamil Nadu Dr.M.G.R Medical University, 
Chennai in partial fulfillment of the rules and regulations for the M.D Degree 
examination in Microbiology. 
     
           
           
      Dr.P.THILAKAVATHY   
Place:  Madurai 
Date: 
 
 
 
ACKNOWLEDGEMENT 
 
 I am grateful to The Dean, Madurai Medical College and                      
Government Rajaji Hospital, Madurai for permitting me to carry out this study. 
 
 I wish to place on the records my deep sense of gratitude and sincere 
thanks to Professor Dr.G.Jayalakshmi M.D;D.T.C.D., Director, Institute of 
Microbiology, Madurai Medical College, for her constant help, guidance and 
encouragement given to me throughout this study. 
 
 I would like to express my sincere thanks to our Professor                      
Dr.P.A.T.Jegadheeswari M.D., for her valuable suggestions, guidance and 
moral support given to me during this study.  
 
 I wish to express my sincere thanks to Dr.Jhansi Charles M.D., 
Professor, for her valuable suggestions, guidance and encouragement given to 
me throughout this study. 
 
 I express my sincere thanks to our professor                      
Dr. R. Vibhusanan M.D., and Professor Dr. V. Dhanalakshmi M.D., and 
Associate Professor Dr.S.Radhakumari M.D., for  their valuable help and 
guidance given to me throughout the study. 
 
 I express my sincere thanks to Assistant Professors               
Dr.S.Ganesan M.D., Dr.S.Lallitha M.D., Dr.C.Sugumari M.D.,             
Dr.N.Ram Murugan M.D., Dr. J. SuryaKumar M.D., Dr. N. Anuradha 
M.D., Dr. M.R.Vasantha Priyan M.D., Dr.M.Kanagapriya M.D., 
Dr.D.Saradha M.D., and Senior Entomologist Mr. John Victor Ph.D for 
their valuable suggestions. 
 
 I am thankful to my colleagues, Dr.T.Rajendran M.D, Dr.B.Divya, 
Dr.A.Seetha, Dr.R.lavanya, Dr.V.Lakshmanakumar, Dr.R.Beaula Lilly for 
their moral support and cooperation rendered during the work. 
 
 I extend my thanks to all staff members, Institute of Microbiology for 
giving full cooperation and timely help in carrying out the laboratory studies. 
 
 Finally I would like to thank all my family members for their esteemed 
moral support rendered during the work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTENTS 
 
S.NO TOPIC PAGE NO 
1. Introduction 1 
2. Aims & Objectives 11 
3. Review of Literature 12 
4. Materials and Methods 28 
5. Results 48 
6. Discussion 61 
7. Summary 70 
8. Conclusion 72 
9. Bibliography  
10. Annexure  
  I-Preparation of Gram stain 
 II-Preparation of Media 
III-Proforma 
Master chart 
Ethical Committee approval form 
Anti plagiarism Certificate 
 
1 
 
INTRODUCTION 
 
   Gram positive bacteria are one of the most common isolates in the 
clinical microbiology laboratory. They are widespread in nature and can 
be recovered from the environment or as commensal inhabitants of the 
skin, mucous membranes and other body sites mostly in human and 
animals. The ubiquity of these gram positive bacteria in nature makes the 
interpretation of their recovery from patients specimens occasionally 
difficult unless clinical manifestations of an infectious disease process are 
apparent. Recovery of these organisms from specimens should always be 
correlated with the clinical condition of the patient before their role in an 
infectious process can be established.[13] 
 
   In 1880, Sir William Ogston, a Scottish surgeon first showed that 
a number of human pyogenic disease were associated with a cluster 
forming microorganism. He introduced the name “Staphylococcus” 
(Greek Staphyle - bunch of  grapes ; kokkos – grain or berry) 
Staphylococci were resistant to dry conditions, high salt concentration 
and are well suited to their ecological niche, which is the skin. In 1884, 
Rosenbach used pigment production to classify Staphylococci as virulent 
Staphylococcus aureus which produces golden yellow pigmentation and 
avirulent Staphylococcus albus, producing white colour colonies.[135] 
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              Major emphasis have been placed by early medical bacteriologist 
in distinguishing Staphylococcus aureus, the pathogenic species from 
Staphylococcus albus, the presumed commensal Staphylococci. Since 
S.aureus was a major cause of morbidity and mortality, this distinction 
was of considerable importance as the clinical specimens often carried 
both types of organisms. The practical value of the coagulating principle 
(coagulase) of  S.aureus was first demonstrated by Von Daranyi(1925) 
and it is  one of the most important tests used to identify this species. In 
the clinical microbiology laboratory, Staphylococci were typically 
categorized as those that have the ability to coagulate rabbit plasma                         
(i.e., coagulase-positive staphylococci or S.aureus) and those that do not 
coagulate (i.e., coagulase-negative staphylococci). The medically 
important Staphylococci comprised of more than 46 described species 
and subspecies.[14] 
 
Based on morphological, physiological and biochemical tests 
Baird-Parker (1963) subdivided the genera Staphylococcus and 
Micrococcus into six subgroups (I to VI). In subsequent schemes, the 
species S.aureus, S.epidermidis, S.saprophyticus were recognized by 
Baird Parker and the latter two species were divided into several biotypes. 
Medical and food diagnostic laboratories widely used  his schemes for 
more than a decade. [14] 
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Coagulase negative Staphylococci (CoNS) are normal commensal 
of skin and mucous membrane and are indigenous to a variety of 
mammalian hosts. Depending on the anatomical site, healthy human skin 
or mucous membrane support from 101 to 106 colony forming 
units(CFU)/cm2 of  Coagulase negative Staphylococci. With more than 40 
recognized species and subspecies, CoNS are the most abundant microbes 
inhabiting the normal skin and mucous membranes. CoNS  infrequently 
causes primary invasive disease and  most commonly encountered by 
clinicians as contaminants of microbiological cultures. With the advent of  
changes in the practice of medicine and changes in underlying host 
populations, CoNS  became formidable pathogens.[3] 
 
Over the past few decades, however these organisms had become 
recognized as important agents of human disease. Infection associated 
with CoNS are urinary tract infections, osteomyelitis, native-valve & 
prosthetic valve endocarditis, intravenous catheter infections, CSF shunt 
infections, peritoneal dialysis  catheter-associated infections, vascular 
graft infections, septicemia, ocular & cutaneous infections.[13] 
 
                   Currently, CoNS are predominant cause of nosocomial bacteremia 
and infect a wide variety of prosthetic medical devices. CoNS are 
frequently encountered in indwelling medical devices and have been 
implicated as a cause of primary bacteremia. The natural niche on human 
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skin which results in easy access to prosthetic medical device inserted or 
implanted across the skin and adheres to biomaterials forming biofilm are 
the two major features owing to pathogenicity of CoNS. CoNS causes 
bacteremia in patients with indwelling medical devices such as permanent 
pacemakers, orthopaedic prostheses, artificial heart valves, central venous 
catheters and other infections involving biofilm formation on implanted 
biomaterials, bacteremia. Indolent infections are often caused by CoNS 
and may be clinically difficult  to diagnose by routine diagnostic 
methods. [3]  
 
          CoNS isolated from nosocomial environments are almost always 
resistant to multiple antimicrobial agents. [136] Phenotypic expression of 
methicillin (oxacillin) resistance in CoNS is much more heterotypic than 
that observed in Staphylococcus aureus and the percentage of the 
population that expresses high -level oxacillin resistance is smaller. [137] 
Regardless of the degree of heterotypy observed, all isolates containing 
mecA (the gene conferring oxacillin resistance) are clinically resistant to 
all β – lactam antibiotics. [138] 
 
         A particular onerous aspect of treatment of most CoNS infections is 
their ability to form biofilms on biomaterials. Treatment could be more 
difficult  due to  increasing rates of resistance to antibiotics  in CoNS  and 
which may due to effect produced by biofilms on  the host defense 
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mechanism. The increasing use of indwelling medical devices will 
augment the biofilm producing strains of CoNS .[3] 
 
Infections caused by CoNS: 
Overall CoNS  has low pathogenic potential and the infection arise 
in the severe immunocompromised state or  associated with prosthetic 
material implantation. Infants who are preterm, low birth weight and 
individuals who are in immunocompromised states such as cancer and 
prolonged chemotherapy renders them neutropenic and susceptible to 
CoNS with the potential to form biofilm and acquire resistance to 
multiple broad spectrum antibiotics.[3] 
 
In case of neonates, within days of their admission to the neonatal 
intensive care unit CoNS colonizes their skin and in their anterior nares, 
pharynx and umbilicus and these organism were not originating from the 
mother but are acquired from the hospital environment and health care 
workers. Low birth weight, the presence and duration of use of central 
venous catheters and umbilical catheters, mechanical ventilation and total 
parenteral nutrition especially with intravenous lipid emulsions are the 
risk factors for developing Coagulase negative Staphylococcal 
bacteremia. CoNS infections in the neonate is frequently associated with 
morbidity and requires prolonged intensive  care in the hospital.[3] 
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Depending on the  host factors, the site where affected and the 
presence or absence of prosthetic material the clinical manifestations of 
CoNS infection varies.    When compared with that of  infection with 
S.aureus, there is a relative lack of the host inflammatory response in  
CoNS infection involving prosthetic material. Device related CoNS 
infection in an immunocompetent individual would usually result in mild 
local signs and symptoms compared with immunocompromised 
individuals who may present with a systemic response, often resulting in 
bacteremia and end organ failure in which the diagnosis of CoNS 
infection will be more difficult.[3] 
 
In contrast to Staphylococcus aureus, which produces an array of 
toxins and adherence factors, there  are few defined virulence factors in 
CoNS.   The ability of the organism to adhere and form biofilm on the 
surface of biomaterials is thought to be the most significant virulence 
factor. However, other factors such as the secretion of poly-gamma-DL-
glutamic acid (PGA) and phenol soluble modulins (PSMs), appear to 
complement and increase virulence.[3] 
 
Biofilms: 
Biofilms are microbially derived sessile communities which are 
characterized by the cells that are  attached to a substratum  in an 
irreversible form.[91] They produce chemotactic particles or pheromones 
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and the bacteria communicate with each other within the biofilm, a 
phenomenon called quorum sensing.[93]  The layers of cell clusters in 
biofilm are embedded in a matrix of extracellular polysaccharide called 
polysaccharide intercellular adhesin (PIA).    The biofilm formation is 
mediated by Polysaccharide Intercellular Adhesion(PIA).[15] PIA is β-1,6-
N-acetylglycosamine and is synthesized b N-acetylglucosaminyl 
transferase. PIA production  is encoded by the  ica gene (intercellular 
adhesion)  which are organized in an operon structure.  Some of the 
factors influencing biofilm formation are availability of  key nutrients, 
surface chemotaxis, bacterial motility, surface adhesins and presence of 
surfactants.[93] According to  a research done on microbial biofilms  by 
National Institutes of Health,  they have published that there is 
involvement of biofilm formation  in more than 80% of all infections.[53]  
Many medical conditions including indwelling medical devices, dental 
plaque, peritonitis, urogenital infections and upper respiratory tract 
infections are associated with formation of  biofilms.[134]  Both Gram-
positive and Gram-negative bacteria have the capability to form biofilms. 
Bacteria commonly involved include Enterococcus faecalis, 
Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus 
viridans, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and 
Pseudomonas aeruginosa.[130]  
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Bacteria survives and multiplies in most environmental niches as 
surface attached biofilms but not as planktonic cells suspended in liquids. 
On abiotic and biotic (host mucosal tissues) surfaces there is development 
of complex communities of single or multiple species of microorganisms. 
The nature of the biofilm and physiological state of bacterial cells within 
the biofilm represents a barrier to eradication and confers high level of 
resistance to antimicrobial agents. So the microorganisms growing in a 
biofilm exihibits intrinsically more resistant to antimicrobial agents than 
planktonic cells. As antibiotic resistance can increase to 500 fold, high 
concentrations of antimicrobials are required  to inactivate organisms 
growing in a biofilm. There are several properties of biofilms that could 
contribute to increased resistance to antibiotics. The exopolysaccharide 
matrix or slime that surrounds the cells may create an exclusive barrier to 
antimicrobials, or directly complex with these agents to inactivate them. 
Suboptimal concentrations of antibiotics may actually enhance antibiotic 
resistance.[14] Bacteria in biofilm grows slowly and slower growth may 
lead to decreased uptake of the drug and other physiologic changes that 
could affect drug resistance.[3] Prevention of CoNS infection has largely 
concentrated on prevention of indwelling catheter - associated infection. 
Catheters should be inserted with meticulous attention to aseptic 
practices. Staff should adhere to appropriate aseptic protocols in caring 
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out the indwelling catheterisation. Prophylactic antibiotics will help in 
slightly slow progression of biofilms in biomaterials.[3] 
 
The critical role in patient management will be removal of the 
colonized devices to eliminate the colonization which will reduce implant 
failure.  Treatment duration depends on the immune status of the host as 
well as persistent presence of implanted prosthetic material. The results 
of antibiotic susceptibility test would be guide in choosing the antibiotic. 
Decolonization of the biofilms along with prolonged antibiotics were 
required for cure and in such cases relapse were not unusual. The major 
attributing factor had been poor penetration of antibiotics into bacterial 
biofilms. A multidisciplinary team approach for the management of 
patients with these often complex conditions could make an important 
contribution towards high standards of care which will reduces the 
hospital stay, implant failure and morbidity in a patients who requires 
critical care in tertiary care hospitals.[14] 
 
Currently, in medical areas various methods are used for the 
detection of biofilm production which includes use of different types of 
microscopes and visual assessment can be done by electron microscopy. 
Confocal laser scanning microscopy (CLSM) remains the most versatile 
and effective nondestructive approach for studying biofilms and markedly 
reduces the need for pretreatments such as disruption and fixation, 
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reducing or eliminating the evidence of microbial relationships, complex 
structures and biofilm organization, encountered with scanning electron 
microscopes without the limitations.[112] However, in the routine 
laboratories qualitative methods such as the tube method(TM), [25]   Congo 
red agar (CRA) method [26] and quantitative methods such as the tissue 
culture plate (TCP)[24] are used. Molecular techniques such as the 
polymerase chain reaction (PCR), which amplifies the genes (ica) 
involved in biofilm production complement these methods. 
 
The present study was undertaken to detect the prevalence of 
biofilm producing and nonproducing CoNS which were isolated from 
various clinical materials in our laboratory by three different phenotypic 
methods such as Congo red agar (CRA) method, Tube method (TM), 
Tissue culture plate (TCP) method, PCR for detection of the ica gene and 
to find out the reliable method from above  which  can be recommended 
for routine detection of biofilm production in CoNS. 
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AIMS & OBJECTIVES 
 
1. To find out the prevalence of CoNS in various clinical samples 
collected from Govt. Rajaji Hospital (GRH), Madurai. 
2. To isolate and characterise the CoNS among the clinical 
samples. 
3. To identify the biofilm producing strains of CoNS in clinical 
isolates by various phenotypic methods. 
4. The antimicrobial susceptibility pattern among the biofilm 
producing and non biofilm producing CoNS isolates.  
5. To compare the various phenotypic methods in the 
identification of biofilm producing CoNS with PCR and to find 
out the most sensitive and economic method which is close to 
PCR that can be recommended for routine screening of Biofilm 
production in Microbiological laboratories.  
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REVIEW OF LITERATURE 
 
 Nosocomial infections are defined as infections acquired during or 
as a result of hospitalization. Generally, a patient who has been in the 
hospital for  < 48 hrs and develops an infection is considered to have 
been incubating the infection before hospital admission. Most infections 
that become manifest after  48 hrs are considered to be nosocomial. A 
patient may develop a nosocomial infection after being discharged from 
the hospital if the organism apparently was acquired in the hospital. 
(Odetola et al )[1] 
 
 Harrison’s Principles of Internal Medicine, (18th ed., 
p.no1112) [2] states that in hospitalized patients, nosocomial infections 
contributes to significant morbidity and mortality as well as to excess 
costs. About 5% of patients admitted to an acute care hospital acquire a 
new infection, with more than 2 million nosocomial infections occurring 
per year and an annual cost of  more than  $ 2 billion. Even though 
factors such as underlying disease and severity of illness play an 
important role in outcome, it is believed that patients who develop a 
nosocomial infection, the odds of death are doubled. Although immune 
suppressed hosts are especially vulnerable to infections acquired in a 
hospital, even  immune competent hosts are also prone to develop  
13 
 
nosocomial infections.  The potential impact of nosocomial infections is 
considerable when assessed in terms of incidence, morbidity, mortality 
and financial burden. 
 
 The most common nosocomial infections are urinary tract 
infections, pneumonia and surgical site infections. However, primary 
bloodstream infections have increased in frequency as have infections in 
medical and surgical Intensive Care Units(ICU’s)  especially those 
associated with intravascular devices. The combined effect of patient’s 
own flora and invasive devices accounts for atleast 25-50% of 
nosocomial infections which highlights the importance of improvements 
in the use of such devices ( Kasper et al )[101]. Slade et al [36] has 
estimated that about 15% to 25% of patients in general hospitals have a 
catheter inserted sometime during their stay and that the use of urinary 
catheters has increased over the last two decades.  
 
 Donlan et al  [91], Raad et al  [97], Souli et al  [98] stated that the use 
of synthetic material for implantation is widely associated with “Implant 
associated infection” due to biofilm production. In the long run they may 
be very damaging because of immune complex disease. [13] It has been 
estimated that 80% of wide variety of microbial infections in the body, 
biofilms have been found to be involved.[53] Infectious processes in which 
biofilms have been implicated include common problems such as urinary 
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tract infections, catheter infections, middle-ear infections, formation of 
dental plaque,[54],[111] gingivitis,[54] coating contact lenses,[55] and less 
common but more lethal processes such as endocarditis, infections in 
cystic fibrosis, infections of permanent indwelling devices such as joint 
prostheses and heart valves,[56] tracheal and ventilator tubing. [57]                                  
( Roger et al [54], Demmer et al [111] , Imamura et al [55],Lewis et al [56],                 
Parsek et al [57]). More recently it has been noted that there is a reduction 
in  topical antibacterial efficiency used for healing or treating infected 
skin wounds as there is impairment in cutaneous wound healing due to 
bacterial biofilm formation stated by Davis et al.[58]  Biofilms can also be 
formed on the inert surfaces of implanted devices such as catheters, 
prosthetic cardiac valves and intrauterine devices documented by                   
Auler et al.[59] 
 
 Most bacteria in natural environments are organized in biofilms                      
( Dalton et al [108], Costerton et al [109],Stickler et al [110]). The first 
recorded observation concerning biofilm was probably given by Henrici 
in 1933 , who observed that water bacteria are not free floating but grow 
upon submerged surfaces (Toole et al ).[90] Biofilm extra cellular 
polysaccharide (EPS), which is also referred to as slime, is a polymeric 
conglomeration generally composed of extracellular DNA, proteins, and 
polysaccharides. Biofilms may form on living or non-living surfaces and 
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can be prevalent in natural, industrial and hospital settings. (Lear et al  
[114], Hall-Stoodley et al [113]). James et al [ 86]  in their study compared 
the bacterial composition of various chronic wound types and 
microscopically analysed the chronic wound tissue specimens using a 
high level electron microscope and revealed that in 60 percent of the 
specimens there is presence of dense colonies of bacteria often 
surrounded by an extracellular matrix. 
 
 There are five distinct stages of biofilm development namely            
1) reversible attachment 2) irreversible attachment 3) maturation 1          
4) maturation 2 and 5) dispersion   (Saucer et al )[14].  
 
 MANDELL [3] explains   that    Biofilm  formation is  thought  to 
occur in three stages-adherent, maturation and dispersal. Biomaterials 
placed within a human host were  rapidly coated with serum matrix 
proteins, including fibrinogen and fibronectin,  collagen,  vitronectin and 
elastin.( Zhang et al, [66]   Nilsson et al, [67]  Hartford et al, [68] Gill et al 
[69], Bowden et al, [70][71]). Autolysins had the ability to bind directly to 
plastic and contain matrix protein binding sites.(Heilmann et al ).[72][73] 
Lipase, in addition to its enzymatic function binds to collagen.[70] 
Following adherence to the biomaterial, intercellular adherence of the 
bacteria was primarily mediated by polymeric molecules. Recently, it had 
been shown that eDNA (extracellular DNA) is a major component of 
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biofilm produced by Staphylococci and mutants defective in DNA 
release produce deficient biofilms( Qin et al,[74]Rice et al)[75]. The last 
stage of biofilm development is dispersal and subsequent spread to other 
potential sites[62].    The production of phenol soluble modulins by the 
organism mediates the detachment of upper layers of the biofilm. PSMs 
were regulated by the quorum- sensing global regulator, which acts as 
surfactant leading to loss of cellular clusters. 
 
           In  device - related bacteremias the most common pathogens 
isolated  include CoNS, Staphylococcus aureus, Enterococci, nosocomial 
GNB and Candida  [Longo et al ].[2]  de Lalla et al [4] stated that the  
predominant organism responsible  for infective complications following  
surgical vascular grafts and implantation of prosthetic devices were Gram 
positive cocci and in particular Staphylococcus species. The 
Staphylococci are members of the family Micrococcaceae that also 
includes Micrococcus, Stomatococcus and Planococcus. These bacteria 
are catalase - positive, gram - positive cocci that divide in irregular 
clusters producing a “grapelike cluster” appearance (Kloos et al )[8] 
 
 O’ Gara et al [7]  has stated that CoNS, although considerably less 
virulent than Staphylococcus aureus, are among the most common cause 
of prosthetic device related infections. In most of the device related 
infections, in about 50-70% of catheter related infections CoNS are 
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responsible as causative organisms (Huebner et al.[6]) These infections 
are generally associated with the use of catheters and other medical 
devices. CoNS are the causative organism in 48-78% of infective 
complications following central nervous system shunt procedures (Roos 
et al 1997), [102]. CoNS are also responsible for a high proportion of 
prosthetic cardiac valve infection (40-50%) (Ing et al ) [103], joint 
replacement infections (20-50%) (Gentry et al ) [104] and majority of 
infections following neurosurgical procedures (Roos et al ) [102] 
 
 Vuong C, Otto M et al .[5]  stated that CoNS infections seems to be 
related to the health condition of the patient and also extracellular 
polysaccharide production. Stoll BJ et al [34] stated that among neonates 
the microorganisms most frequently encountered in nosocomial 
infections are the Coagulase-negative staphylococci (CoNS). In neonatal 
intensive care units (NICU) the most-frequent cause of late-onset sepsis 
among newborn infants are Coagulase-negative staphylococci (CoNS). 
Incidences of up to 66% of late-onset sepsis have been reported (Vishal 
Hira et al). Due to high rate of invasive procedures in immune 
compromised patients and also the bacterium’s ability to form biofilms 
there is increased occurence of these infections. Biofilm producing 
Staphylococci frequently colonize catheters and medical devices and may 
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cause foreign body related infections. They easily get attached to 
polymer surfaces (Thomas et al [93], Murray et al[94], Schwank et al [95]) 
 
 Bannerman and Peacock et al [9] has stated that Staphylococcus 
epidermidis is  the most frequently encountered CONS species associated 
with human infections and  particularly associated with intravascular 
catheters. In indwelling medical device infections such as prosthetic-
valve endocarditis, surgical wounds, central nervous system shunt 
infections, intravascular catheter-related infections, peritoneal dialysis-
related infections, and infections of prosthetic joints, the predominant 
agent of nosocomial bacteremia is S. epidermidis.  S. haemolyticus is the 
second most frequently encountered CONS species and has been 
implicated in native-valve endocarditis, septicemia, peritonitis, and 
wound, bone, and joint infections. Other CONS species are involved in a 
variety of infections. For example, in human urinary tract infections, 
especially in young, sexually active females the important pathogen is 
S.saprophyticus. S.lugdunensis has been implicated in arthritis, catheter 
infections and prosthetic joint infections. CoNS species were identified 
using the standard biochemical tests which includes catalase, DNase, 
coagulase production, growth and fermentation of mannitol on mannitol 
salt agar and susceptibility tests to bacitracin and novobiocin             
(Kloos et al ) [8] 
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 Archer et al [60] states that Staphylococcus epidermidis is the most 
frequently recovered organism accounting for 50% to over 80% of 
isolates.  Staphylococcus epidermidis emerged as pathogen and has been 
synchronous with the widespread use of intravascular catheters in 
modern medicine. The inherent capacity of this organism to cause 
infection derives primarily from its ability to form biofilms on the inert 
substances of indwelling medical devices. Rupp and Archer; Kloos and 
Bannerman et al [10] has stated that in immunocompromised patients, 
S.epidermidis has emerged as a common cause of nosocomial infections. 
Septicaemia due to S. epidermidis is often associated with the use of 
catheters and other indwelling medical devices stated by Kloos and 
Bannerman; Pfaller and Herwaldt; Peters et al [11],[12]. The prevalence 
of methicillin - resistant Staphylococcus epidermidis (MRSE) strains 
(Giacometti et al [105],  Jarlov et al [106],Tammelin et al [107]) and the 
emergence of vancomycin resistant in this species further complicate 
treatment of biomaterial infections. 
 
 Rupp et al  [40][41] stated that the major virulence factor of  
S.epidermidis is the ability to adhere on the surface of biomaterials  and 
form biofilms. other virulence factors such as  Poly-Gamma-DL-
Glutamic Acid(PGA), Lantibiotics documented by  Kocianova et al [76] 
Vuong et al[77] S.epidermidis  produces PGA. PGA is a cell surface – 
20 
 
associated, antiphagocytic polymer first described as a virulence factor in 
Bacillus anthracis.[78] PGA has bifunctional role and functions to inhibit 
innate host defense as well as facilitate colonization of human skin. 
S.epidermidis produces several lantibiotics (eg., epidermin, Pep5, 
epilancin, epicidin) which are bacteriocins. These thio-ether aminoacid – 
containing antimicrobial peptides are active against a variety of bacteria 
and may play a role in bacterial interference and successful colonization 
and persistence on human skin.(Kupke et al ).[79] The major pathogenic 
factor in biofilm formation is mediated by a Polysaccharide Intercellular 
Adhesion(PIA) documented by  Eftekhar et al. [15] 
 
 Koneman’s textbook of diagnostic microbiology[13]   explains  the  
Biofilm  formation  by  Staphylococcus  epidermidis :   Staphylococcus 
epidermidis  strains    from   infections       of      indwelling     medical    
devices    have    shown   that  these bacteria produce cell-surface and 
extracellular macromolecules that initiate and subsequently enhance 
bacterial adhesion to the plastic surfaces of foreign bodies to form a 
biofilm. Initial specific adherence to be largely mediated by a capsular 
polysacch aride-adhesin called PS/A(Muller et al)[79] PS/A is a high 
molecular weight, variably N-succinylated,β-1,6-linked polyglucosamine 
molecule that is encoded by the ica locus of the Staphylococcus 
epidermidis genome (McKenney et al ).[80] Purified PS/A can block 
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adherence of PS/A - producing S.epidermidis to plastic catheters in vitro, 
antibodies directed against PS/A also appear to block adherence to 
biomaterials. PS/A is also able to protect the organisms from complement 
mediated phagocytic killing (Muller et al [79], Shiro et al).[81][82] 
Following initial adherence to biomaterials, pathogenesis of 
S.epidermidis infection apparently involves adhesion between cells that 
are adherent to the plastic surface, forming the rest of the bacterial 
cell/polysaccharide matrix biofilm.(Aricola et al ).[51]  Intercellular 
adhesion is mediated by a polysaccharide called PIA (Polysaccharide 
Intercellular Adhesion) along with some other cell -associated proteins 
(Mack et al ).[83] PIA in the initiation and synthesis of biofilms on 
biomaterials is supported by studies with animal models documented by 
Rupp et al.[17],[84] 
 
 Mack D et al [16]  stated that the layers of cell clusters in biofilm 
are embedded in a matrix of extracellular polysaccharide called 
polysaccharide intercellular adhesin (PIA), which consists of β-1,6-N-
acetylglycosamine and is synthesized by N-acetylglucosaminyl 
transferase. Nilsdotter - Augustiinsson et al [18] documented that the 
products of the chromosomal ica gene(intercellular adhesion)  mediates 
the synthesis of PIA , which are organized in an operon structure. This 
operon contains the icaADBC genes, in addition to the icaR gene which 
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exerts a regulatory function and is transcribed in the opposite direction. 
Four proteins are transcribed after activation of this operon namely IcaA, 
IcaD, IcaB and IcaC , which are necessary for the synthesis of PIA. 
 
 Recent studies have shown that accumulation-associated protein 
(Aap), DNA and RNA independently or in cooperation with the ica 
operon  are the additional components, have also been suggested to be 
involved in CoNS biofilms  stated by Chokr et al.[19] Tomo et al [20] 
documented that in the initial attachment, intercellular adhesion and 
biofilm formation of Staphylococcus aureus there has been association of 
Bap [biofilm-associated protein]. Interestingly, an alternative mechanism 
of biofilm formation that does not depend on PIA has been induced by  
Bap homologue protein (Bhp) and is found in human S. epidermidis 
strains.  
 
 Mack et al [30]; Cramton et al [32]; Rachid et al [33]; Cerca             
et al [31]; Eftekhar and Speert[15] documented that the amounts of 
biofilm produced in vitro by S.epidermidis are highly variable and 
greatly influenced by glucose and other environmental and growth 
conditions. Kim L. Riddle et al[35]   has documented that many 
recalcitrant infections  produced by biofilm producing bacteria are  
notoriously difficult to eradicate. Resistances to antibiotics were 
exhibited by various mechanisms like restricted penetration of antibiotic 
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into biofilms, decreased growth rate and resistant gene expression. 
Klingenberg C, Aarag E, Ronnestad A et al[38] stated that the biofilm 
protects CoNS against the action of antibiotics administered for the 
treatment of these infections and also against the patient’s immune 
system and for cure, it is often necessary to remove the foreign body. 
Afreenish Hassan et al[37] documented in their study that biofilm 
producing bacteria had higher antibiotic resistance than non-biofilm 
producers. 
 
 Several genetic regulation mechanisms have been implicated in 
biofilm regulation such as quorum sensing and the novel secondary 
messenger cyclic-di-GMP unveils the rapid progress in biofilm research. 
Understanding the molecular mechanisms of biofilm formation has 
facilitated the exploration of novel strategies to control bacterial biofilms 
stated by An S et al.[85]  
 
 Zufferey et al[29],Freeman et al[26],Christensen et 
al[24],[25],Donlan et al[27], Aparna et al[28] has documented various 
methods of  detection of biofilm formation which includes Tissue Culture 
Plate (TCP)[24], Tube method (TM)[25], Congo Red Agar method 
(CRA)[26], bioluminescent assay, piezoelectric sensors, and examination 
by fluorescent microscopy.[29] Afreenish Hassan et al[37] compared  
various methods to detect biofilm formation (TM , CRA & TCP 
24 
 
methods), and concluded that the for detection of biofilm producing 
bacteria, TCP can be recommended as a general screening method. 
Mathur et al[39] has documented that  out of 152  Staphylococcal  isolates 
tested, by TCP 53.9 % were biofilm producers and 46% were  non-
biofilm producers, performed by  addition of 1% glucose in trypticase 
soy broth. 
 
 Adilson Oliveira et al[42] has investigated production of biofilm by 
the tube adherence test, among the 82 of the 100 isolates of CoNS were 
found to be  biofilm producers, which includes 44 strains isolated from 
catheter tips, 23 isolated by blood culture, and    15 isolated from nares 
specimen. Bose et al[41]has stated that the TCP is the better screening test 
for biofilm production than CRA and TM.  The test is easy to perform 
and assess both qualitatively and quantitatively.  In his study, positivity 
rate of CRA method was higher than observed by other workers. 
Ruzicka et al[43] noted that among 147 isolates of S. epidermidis, biofilm 
formation detected by TM  is 79 (53.7%) and 64 (43.5%) isolates  by 
CRA and documented that TM is better for biofilm detection than CRA. 
Baqai et al[44] studied the biofilm formation among uropathogens by TM.  
According to their results, biofilm formation was detected by TM in 75% 
of the isolates CRA detected  biofilm production in only 11isolates  and 
99 as non-biofilm producers. The sensitivity (11%), specificity (92%) 
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and accuracy (41%)  of CRA method were very low when compared with 
other methods. 
 
 Knobloch et al[45]  recommended  the TCP  method for detection of 
biofilm.   Out of 128 isolates of S. aureus, 3.8% were detected as biofilm 
producers by CRA as compared to TCP which detected 57.1% biofilm 
producers. Morales et al[89], Cunha et al[88] documented that TCP assay 
provides reliable result for biofilm detection in CNS and is adequate for 
routine use. CoNS growing within biofilm consists of atleast four 
metabolic states : aerobic growth,  anaerobic growth, dormant cells and 
dead cells.[64] Lewis et al [65]  hypothesized that these unique physiologic 
states found within a biofilm allow for tolerance to antibiotics and 
development of persister and dormant cells. Crampton et al [96] showed 
that like S epidermidis, S aureus also has ica locus encoding the function 
of intracellular adhesion and biofilm formation. 
 
 Gad et al[99], Cafiso et al[100] demonstrated the molecular 
technique(PCR) is more efficient in detecting the genes of the ica operon. 
In addition, these genes are important virulence markers of clinical CNS 
isolate since their expression is associated with the production of PIA, the 
most clearly characterized component of staphylococcal biofilms. 
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 Aricola et al[46]; Ziebuhr et al [47]; Galdbart et al [48]  suggested  
that a good predictor of biofilm formation for distinguishing blood and 
catheter related infecting organisms from contaminating bacteria is the 
detection of the ica locus in S.epidermidis. de Silva et al[49]   evaluated 
the hypothesis  that there is association of ica operon and biofilm 
production and concluded  that the quantity of biofilm produced may be 
associated with the ability to cause CoNS infection.  This conclusion 
suggests that the regulation of biofilm expression may play a central role 
in the disease process. Gerke et al[21], Freeman et al[22] stated that the ica 
operon consisting of icaA, icaD, icaB and icaC genes  mediates the 
synthesis of PIA production in S.epidermidis and is regulated by the 
product of icaR. Nacetylglucoseaminyl transferase which synthesizes the 
PIA polymers is encoded by IcaA and D and icaC is responsible for 
formation of long polymer chains and icaB deacetylates the poly-N-
acetylglucoseamine molecule.  
 
 Seung – Hak - Cho et al[23] has analyzed 41 S.epidermidis isolates 
obtained from catheter-related urinary tract infections for the presence of 
the icaADBC operon and biofilm formation and found that  ica-specific 
DNA was present in  18 out of 41 isolates (44%),  but only 11 isolates 
(27%)  produced biofilms spontaneously under normal growth 
conditions. Upon induction by external stress or antibiotics, biofilm 
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formation could be stimulated in five of seven ica-positive, biofilm-
negative isolates, indicating that the icaADBC expression was down-
regulated in these strains.  
 
 Galdbart, J. O.,et al[50] studied the association of S.epidermidis 
isolated from  prosthetic material related joint infection and demonstrated 
that ica  was positive in 44 out  of 54 isolates, compared with 2 of 23 
isolates from eight healthy individuals. Arciola, C. R[51]  documented 
that out of 68 S.epidermidis isolates  associated with intravenous-
catheter-related infection  ica was positive in  33 isolates compared with 
none of 10 isolates from the skin or mucosa of healthy volunteers. 
Frebourg, N. B[52]  showed that ica  was more than twice as frequent in 
isolates associated with infection when he compared  the  ica  gene  in                          
S.epidermidis associated with either bacteremia, blood culture 
contamination, or colonized intravenous devices and S. epidermidis from 
normal flora of healthy volunteers who were not hospitalized. 
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MATERIALS AND METHODS 
 
 The present study was conducted in Government Rajaji Hospital, 
Madurai, attached to Madurai Medical College. The study period was 
from June 2011 to May 2012. Ethical committee clearance from the 
institution was obtained before starting the study and informed written 
consent was received from the patients before collecting the specimens. 
A total of 456 clinical samples were collected from the patients admitted 
in various wards at Government Rajaji Hospital, Madurai. 
 
SOURCE AND SAMPLE SIZE: 
 Pus, wound swab samples (from infected bone & joint prosthetic 
implants, surgical site infections), indwelling catheter samples, blood 
samples, urine samples were collected from 456 patients admitted at 
Govt. Rajaji Hospital during the study period. 
 
INCLUSION CRITERIA: 
1. All age groups and both sexes were included  
2. Patients admitted to various wards (ICU, CCU, IRCU, 
Orthopeadic, plastic surgery, medicine)  with signs and symptom 
suggestive of impending infections such as infected implants, 
surgical site infection, urinary tract infection, septicemia, pyrexia 
of unknown origin were included in this study. 
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COLLECTION OF SPECIMEN: 
COLLECTION OF  BLOOD SAMPLE: 
 Blood samples were collected  by sterile aseptic procedures . The 
hands were kept clean and dry, sterile gloves were worn. The skin over 
the venepuncture site was disinfected by applying 70%  alcohol followed 
by 1% iodine or 1-2% chlorhexidine for atleast 1 min and allowed to dry. 
With precautions to avoid touching and recontaminating the 
venepuncture site, 5 ml of blood was withdrawn. The withdrawn volume 
of blood was inoculated into the appropriate volume of  brain heart 
infusion broth. 
 
COLLECTION OF URINE SAMPLES : 
 Urine sample was collected from catheterized patients. Urinary 
catheterization will allow collection of bladder urine with less urethral 
contamination. Specimen collection from such patients was done with 
scrupulous aseptic techniques. A pair of gloves were worn while 
handling urinary catheters. The catheter tubing was clamped off above 
the port to allow collection of freshly voided urine. With 70% alcohol, 
clean vigorously the catheter port or wall of the tubing and by using 
sterile syringe with needle aspirate the urine, introduction of organisms 
into the bladder was prevented by maintaining the integrity of closed 
drainage system. The collected urine transported in a sterile, wide 
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mouthed, screw capped container. Clean catch midstream urine sample 
was collected from other patients with proper instructions.  
 
COLLECTION OF WOUND SWAB SAMPLE: 
 Two sterile cotton swabs were used to collect the samples from  
patients, which can be used for direct smear examination and culture 
respectively. The swabs were transported in sterile test tubes to the 
laboratory. 
 
COLLECTION OF PUS SAMPLE: 
 The site from which the culture was to be obtained should first be 
decontaminated with 70% ethyl or isopropyl alcohol. After which the 
wound was washed well with sterile saline and dried. Using sterile 
syringe and needle, pus was aspirated and then specimen transported in a 
puncture proof container. 
 
PROCESSING OF SAMPLES: 
 The collected samples were properly labeled with Name. Age, Sex 
and    IP / OP no of the patient, date and time of collection of the sample 
and brought to the laboratory and processed immediately.  
 
WOUND SWAB AND PUS SAMPLES: 
 Direct Gram stain was done on samples followed by inoculation on 
to the following solid media  
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a) Nutrient Agar  
b) Mac Conkey Agar 
c) Blood Agar 
 
BLOOD SAMPLES: 
 Blood culture broth were incubated at 370C for 18-24 hrs after 
which the broth were examined for turbidity and subcultured in to above 
solid media for isolation of organisms. The broths which were clear kept 
for further incubation. 
 
URINE SAMPLES: 
 Urine samples were inoculated on to the NA, Mac Conkey, Blood 
agar. Before inoculation, urine was mixed thoroughly and the top of the 
container was then removed. The calibrated loop was inserted vertically 
into the urine in a cup. The centre of the plate was touched with the loop 
and the inoculum was spread in a line across the diameter of the plate. 
Without flaming or re-entering urine, the loop was drawn across the 
entire plate, the first inoculum was crossed numerous times to produce 
isolated colonies. A colony count of >105 CFU/ml ml was taken as 
indicative of a positive culture . 
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CULTURE IDENTIFICATION: 
 After 24 hr of incubation, plates were examined for the presence of 
growth and the organisms were identified by Gram stain, colony 
morphology on solid media and biochemical reactions and other 
identification tests. 
 
IDENTIFICATION OF COAGULASE NEGATIVE STAPHYLOCOCI 
(CoNS): 
1. Gram staining      : Gram positive cocci arranged in clusters 
2. Catalase test         : Positive 
3. Nutrient agar        : Small, circular, low convex, opaque colonies 
4. Mannitol               : Not fermented 
5. Tube Coagulase test : Negative    
6. DNase test            : Negative 
 
SPECIES IDENTIFICATION OF CoNS: 
 Based on biochemical assays such as production of  Phospahatase, 
Susceptibility to Novobiocin, Ornithine decarboxylase test and Beta 
hemolysis on Blood agar, species of CoNS were identified. 
Staphylococcus epidermidis was the most frequently encountered CONS 
species followed by S.saprophyticus, S.lugdunensis & S.haemolyticus. 
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IDENTIFICATION TESTS: 
GRAM STAINING:  
 Smear was prepared from the test organism taken from the agar 
plate, air dried and heat fixed. The smear was flooded with 0.5% methyl 
violet and washed with water after 1 minute. Then Gram’s iodine is 
added to the smear and washed with water after 1 minute. This was 
decolorized with few drops of acetone and immediately washed with 
water. The counter stain, 1:10 dilute carbol fuchsin was added to the 
smear and washed with water after 1 minute, the smear was dried with 
blotting paper and viewed under oil immersion objective. Violet colored 
spherical cocci arranged in clusters were identified as Gram positive 
cocci. 
TEST S.epidermidis S.haemolyticus S.lugdunensis S.saprophyticus 
NOVOBIOCIN          S         S       S        R  
PHOSPHATASE          +          _       _        _  
ORNITHINE  
DECARBOXYLASE  
        _          _       +        _  
β -HEMOLYSIS          _           +       _        _  
34 
 
CATALASE TEST: (Tube method) 
Procedure: 
 Two to three ml of 3% Hydrogen peroxide was taken in a clean 
test tube. Few colonies of the test organism were taken from the nutrient 
agar plate with a sterile wooden stick or glass rod and immersed in the 
Hydrogen peroxide solution. 
 
Interpretation: 
 Brisk effervescence produced immediately is considered as 
Catalase positive. The organisms producing Catalase will split Hydrogen 
peroxide into water and oxygen, and the effervescence was due to release 
of nascent oxygen.   The genus Staphylococci were catalase positive. 
 
COAGULASE TEST:  
 This test was done to identify Coagulase negative Staphylococci 
from Staphylococcus aureus. The enzyme coagulase causes clotting of 
plasma by converting fibrinogen to fibrin. There are two types of 
coagulase :  
 a) Free Coagulase: it activates coagulase reacting factor present in 
plasma and  converts fibrinogen to fibrin resulting in clot formation. 
 b) Bound Coagulase (clumping factor) which converts fibrinogen 
to fibrin not depending on reacting factor. It can be detected by clumping 
of bacterial cells in the rapid slide test. 
35 
 
Procedure : 
Slide Test Method: 
1. Place a drop of saline on each end of a clean slide. 
2. Make two thick suspensions by emulsifying the colony of test 
organism with each of the drops. 
3. To one of the suspension add a loopful of rabbit plasma and mix it 
gently, plasma was not added to 2nd suspension which was used as a 
control. 
  
Interpretation:  
 Positive  slide Coagulase test :  Clumping within 10 seconds. 
 Negative slide Coagulase test :  No clumping. 
 
Tube Test Method:  
Procedure: 
1. Three small clean test tubes were taken. One tube was used for 
testing the isolate from primary culture plate. Emulsify a small 
amount of the colony growth of the organism in a tube containing 
0.5ml of undiluted rabbit plasma.  
2. The other tubes were used as positive and negative controls. A 
known Staphylococcus aureus strain and a Staphylococcus 
epidermidis strain serve as positive and negative controls. 
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3. The tubes were incubated at 350C for 4 hours and observe for clot 
formation by gently tilting the tube. If no clot was observed at that 
time, the tubes were reincubated at room temperature and read after 
18 hours 
  
Interpretation:  
 Positive tube Coagulase test: Clotting of tube contents or fibrin clot 
in tube. 
 Negative tube Coagulase test: No clotting. 
 
DNase TEST:  
 This test was done to identify CoNS which incapable of producing 
deoxyribonuclease (DNase) enzyme  from S.aureus  which produces 
DNase enzyme, which is capable of hydrolyzing DNA. 
 
Procedure : 
1.  The DNase agar plate was divided into sections by drawing lines 
on its bottom and the sections were numbered to denote the strain 
to be applied to them. 
2. A colony was picked from the primary culture plate spot 
inoculated on to a  small area of the medium. 
3. Known DNase positive and DNase negative cultures were spot 
inoculated on other sections as control. The plate was kept for 
overnight incubation.  
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4. Then the plate was flooded with a few ml of 1 mol/L, 3.6% 
hydrochloric acid to  precipitate unhydrolysed DNA. 
5. The plate was examined within 5 minutes. 
 
Interpretation:  
           DNase positive strain  : Clearing around the colonies.  
                    DNase negative strain :  No clearing around the colonies 
 
TEST FOR SPECIES IDENTIFICATION OF CoNS: 
PHOSPHATASE TEST: 
Culture growth was inoculated on to Phenolphthalein diphosphate 
agar medium and kept for overnight incubation. After overnight 
incubation a few drops of ammonia solution added.  
 
Interpretation :  
 Positive colonies turned pink within a few minutes. S.epidermidis 
produces phosphatase enzyme. 
 
NOVOBIOCIN SUSCEPTIBILTY TEST: 
 The novobiocin test is performed as a disk susceptibility test using 
a novobiocin disk (5µg). The test done by including a 5µg novoobiocin 
disc in the disc diffusion test for antibiotic sensitivity. 
 
38 
 
Interpretation: 
 Strains resistant to novobiocin will show zones measuring 6 mm 
(no zone) to  12 mm; susceptible strains will have zones of 16 mm or 
larger. S.saprophyticus is novobiocin resistant. 
 
ORNITHINE DECARBOXYLASE TEST: 
 For determining the decarboxylase capability Moeller 
decarboxylase medium was used as the base. Before inoculating the test 
organism ornithine was added to the base. The base without the amino 
acid is kept in a tube as control. Inoculate both the two tubes with the test 
organism.  Both the  tubes were overlaid with  sterile mineral oil to cover 
about 1 cm of the surface and then kept for incubation. S.lugdunensis 
produces ornithine decarboxylase enzyme. 
 
Interpretation:  
 Violet colouration of the medium denotes production of the 
decarboxylase, and a yellow colouration as a negative reaction. 
 
ANTIBIOTIC SUSCEPTIBILITY TEST: 
PREPARATION OF INOCULUM: 
 Morphologically similar 4 to 5 isolated colonies  of CoNS were 
taken from 24 hr culture plate with the help of a sterile loop and 
transferred to a test tube containing sterile peptone water and incubated 
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for 4 hrs at 350C . Then the turbidity was adjusted to 0.5 McFarland 
turbidity standards by using Vickeum chart. This inoculums was used for 
antibiotic susceptibility testing . 
 
 According to CLSI guidelines (CLSI document M02-A10), the 
antibiotic susceptibility test was performed by using the Kirby-Bauer disc 
diffusion technique. Mueller Hinton agar was used for antibiotic 
susceptibility test. Zone size was interpretated using control strain 
Staphylococcus aureus (ATCC 25923) and following antibiotic discs 
were used.  
 
Antimicrobial Drug S I R 
Ampicillin  (AMP 10µg) ≥29 - ≤ 28 
Gentamicin (GM 10µg) ≥ 15 13 – 14 ≤ 12 
Ciprofloxacin (CIP 5µg) ≥ 21 16 – 20 ≤ 15 
Cefotaxime (CTX 30µg) ≥ 23 15 – 22 ≤ 14 
Chloramphenicol (C30 µg) ≥ 18 13 – 17 ≤ 12 
Cotrimoxazole (COT 25 μg) ≥ 16 11 – 15 ≤ 10 
Erythromycin (ERM 15µg) ≥ 23 14 – 22 ≤ 13 
Doxycycline(DOX 30µg) ≥ 16 13 – 15 ≤ 12 
 
Zone size(mm): S- sensitive, I- intermediate, R- resistant 
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DETECTION OF BIOFILM PRODUCTION : 
 Detection of biofilm production in CoNS isolates was done by the 
following methods : 
1..Congo Red Agar method (CRA) 
2.Tube method (TM) 
3.Tissue Culture Plate (TCP) 
4.Detection of  ica genes by PCR. 
 
CONGO RED AGAR METHOD: 
 A qualitative method for detection of biofilm production and 
medium used was Congo Red Agar (CRA) medium 
 
Procedure 
 The test organisms were inoculated in CRA and kept for 
incubation at 37oC for 24 h aerobically. 
 
Interpretation:  
Biofilm producer: 
 
Colony morphology 
High colonies with black colour and a 
dry crystalline consistency 
Moderate darkening of the colonies without 
dry crystalline consistency 
Weak/Non-biofilm producers pink colored colonies. 
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TUBE METHOD: 
 A qualitative method for detection of biofilm production. 
Procedure:  
1 The test organisms were inoculated in 10 mL of trypticase soy 
broth taken in the sterile test tubes.The tubes were kept for 
incubation. 
2 Then the tubes were decanted and by using  phosphate buffer 
saline  pH 7.3)  the tubes were washed and  then allowed to 
dry. 
3 By using safranin (0.1%) the tubes were stained and deionized 
water was used to remove excess stain.  
4 Tubes were kept in inverted position and allowed to dry. The 
control strains were included in the test and according to the 
results  the scoring  was done  
 
Interpretation:  
Biofilm production:  
• The wall and the bottom of the tube were lined by a visible film. 
• The amount of biofilm formed was scored as 1- weak/none, 2- 
moderate,  3-strong. 
 
TISSUE CULTURE PLATE METHOD: 
 This is a quantitative method for biofilm detection.  
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Procedure: 
1 The test organisms were inoculated in10 mL of trypticase soy 
broth broths and kept for  overnight incubation. 
2 A dilutions of :100 was done for the cultures by using fresh 
medium. Add 200 μL of the diluted cultures into individual 
wells of sterile   96 well flatbottom polystyrene tissue culture 
and then incubated. 
3 Then the organisms  used for control (positive and negative) 
were diluted and added to the microtitre plate and kept for 
incubation [Staphylococcus epidermidis ATCC 35984 
(biofilm producer) and ATCC 12228 (biofilm nonproducer)]  
4 Then gentle tapping was done to remove the contents of the 
well 
5 Washing of the wells was done with 0.2 mL of phosphate 
buffer saline (pH 7.2) and then  wells were washed four times 
to remove the free floating bacteria. 
6 After washing 2% sodium acetate was used to fix adherent 
bacteria in the wells and by using crystal violet (0.1%) the 
wells were stained  and deionized water was used to remove  
excess and then allowed to dry. 
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7 Reading was taken at wavelength 570 nm by micro ELISA 
autoreader. As the bacteria forms biofilm and adheres to the 
wells, these OD values were taken  as an index of bacterial 
adherence to the wells. 
 
Interpretation: 
 
Mean OD values 
 
Biofilm production 
<0.120 Non/weak 
0.120-0240 Moderate 
>0.240 High 
                  OD cut off value = average of negative control  
                        +3x standard deviation (SD) of negative control. 
 
DETECTION OF icaADBC GENE: 
POLYMERASE CHAIN REACTION (PCR) 
            PCR was done by the following protocol to detect ica gene in 
CoNS isolates. 
DNA extraction from CoNS isolates: 
1 1.5 ml of overnight CoNS culture was transferred to 1.5 ml 
centrifuge tube. 
2 Centrifuged at 10000 rpm for 5 mins; supernatant discarded. 
3 Bacterial Pellet is suspended in 200µl of PBS 
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4 50µl of Lysozyme [50mg/ml] is added and Incubated at 37ºC for 
15min. 
5 Added 400µl of Lysis Buffer and 40µl of Proteinase K 
[Reconstituted] 
6 Mix immediately by inverting and incubate at 70ºC for 10min. 
7 Added 100µl of Isopropanol and mixed well. 
8 Pipetted entire sample into the PureFast® spin column.After 
centrifuging for   1 min discard the flow through and column was 
placed back into the same collection tube. 
9 Added 500μl Wash Buffer-I to the PureFast® spin column. After 
centrifuging for 30-60 seconds  discard the flow-through and the 
column was placed back into the same collection tube. 
10 Added 750μl Wash Buffer-II to the PureFast® spin column. After 
centrifuging for 30-60 seconds  discard the flow-through and the 
column was placed back into the same collection tube. 
11 Repeat Step 8 once. 
12 After discarding the flow-through  an  additional centrifugation for 
1 min was done to avoid residual ethanol. 
13 PureFast® spin column is transferred into a fresh 1.5 ml micro 
centrifuge tube. 
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14 Added 100μl of the pre-warmed Elution Buffer to the PureFast® 
spin column. 
15 Then incubated for two minutes at room temperature and 
centrifuged for two minutes.   
16 Discard the column and stored the purified DNA at -20°C.  For gel 
analysis, 
loaded 10 - 20µl of elute. 
 
PCR Procedure: 
Reactions set up as follows; 
Components :( total volume - 50µl) 
1 Mastermix - 25µl 
2 ica primer (10pmoles/µl)  
F -  iCA-F-TCCAGAAACATTGGGAGGTC 
ica primer (10pmoles/µl)  
R - iCA-R-TGGGTATTCCCTCTGTCTGG     
3 Nucleus free water 22 µl 
4 Test samples (Genomic DNA) 1µl Mixed gently and spin down 
briefly. 
5 Place into PCR machine and program it as follows; 
      Program: ( total cycles run – 30) 
      Initial Denaturation: 94ºC for 3 min 
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 Denaturation :     94ºC for 1 min 
 Annealing     :     58ºC for 1min                  30 cycles 
 Extension     :     72ºC for 1min 
 
Agarose gel electrophoresis: 
1. Prepared 2% agarose.   
2. When the temperature of agarose gel was around 60ºC, 5µl of 
Ethidium bromide was added. 
3. Warm agarose solution  was poured slowly into the gel platform.   
4. The gel was kept  undisturbed till the agarose sets and get solidified. 
5. To the submarine gel tank ,1XTAE was poured. 
6. The gel platform is carefully placed into tank and a buffer level 0.5cm 
was maintained above than the gel. 
7. After mixing with the gel loading dye and 10µl 100bp DNA Ladder 
the PCR Samples were loaded.  
8. Run electrophoresis at 50V till  three fourth distance had been reached 
in the gel. 
9. UV Transilluminator was used to view the gel and the bands pattern 
were observed.  
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Interpretation: 
             The presence of ica gene was indicated by the amplification of 
100bp PCR product from the clinical isolates. 
 
STATISTICAL EVALUATION: 
 Considering the PCR as the standard test, statistics was applied for 
calculating Sensitivity, Specificity, Positive Predictive Value (PPV), 
Negative Predictive Value (NPV) for each method .  
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RESULTS 
 
 Samples of pus, wound swab, blood and urine collected from 456 
cases admitted at Govt.Rajaji Hospital, Madurai were included in this 
study. This study included both sexes of all age group. Out of 456 
samples, 165 from wound swab, 103 from  pus,  96 from blood and 92 
from  urine. Among the 456 samples,  424 showed growth  and 32 
samples showed no growth. Among the 424 isolates, 252 Gram positive 
cocci (GPC) in groups were Staphylococci species and  172 were Gram 
negative bacilli (GNB). 
 
Table -1 
SPECIMEN WISE ISOLATION OF ORGANISMS 
n=456 
Specimen Staphylococci GNB No growth Total 
Wound swab  108(23.68%) 51(11.18%)   6(1.32%) 165 
Urine   55(12.06%) 34(7.45%)   3(0.65%)   92 
Blood   54(11.84%) 30(6.58%) 12(2.63%)   96 
Pus   35 (7.68%) 57(12.50%) 11(2.41%) 103 
Total 252(55.26%) 172(37.71%) 32(7.01%) 456 
  
 Among the 252 Staphylococci species, 108 were isolated from 
wound swab, 55 from urine specimen, 54 from blood and 35 from pus 
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samples. From the above observation it is inferred that Staphylococcal 
species were the common isolates in various clinical specimens and 
wound swab specimen was the common specimen in which more 
Staphylococci were isolated. 
 
 Out of 252 Staphylococci species, 96 were found to be Coagulase 
test negative and 156 were Coagulase test positive. 
 
Table – 2 
IDENTIFICATION  OF COAGULASE NEGATIVE 
STAPHYLOCOCCI   (CoNS) 
n=25  
Tube Coagulase test 
Staphylococci 
(no of isolates) 
Positive 156(61.9%) 
Negative   96(38.1%) 
  
 From the above table it is inferred that nearly 1/3rd of 
Staphylococcal species were Coagulase negative Staphylococci.  
 
 Among the 96 CoNS, 31 were isolated from wound swab, 28  from 
blood, 19 from urine specimen and 18  from pus specimen. 
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Table - 3 
SPECIMEN WISE ISOLATION OF CoNS 
n=96 
Specimen No.of cons isolates Percentage 
Wound swab 31 32.29% 
Blood 28 29.17% 
Urine 19 19.79% 
Pus 18 18.75% 
  
From the above observation it was found that CoNS was isolated 
more from wound swab samples. 
 
 Out of 96 CoNS isolates, 76 isolates were Staphylococcus 
epidermidis,  5 isolates were Staphylococcus haemolyticus, 3 isolates 
were Staphylococcus lugdunensis, 3 were Staphylococcus saprophyticus 
and 9 were other species of  CoNS.  
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Table -4 
SAMPLE WISE IDENTIFICATION OF CoNS SPECIES 
n=96 
Specimen 
Staphylococcus 
Epidermidis 
Staphylococcus 
Haemolyticus 
Staphylococcus 
Lugdunensis 
Staphylococcus 
saprophyticus 
Other 
species 
Total 
Wound swab 
 
26 
(27.08%) 
 
2 
(2.08%) 
1 
(1.04%) 
- 2 (2.08%) 31 
Blood 
 
22 
(22.92%) 
 
2 
(2.08%) 
1 
(1.04%) 
- 3 (3.13%) 28 
Urine 
 
16 
(16.67%) 
 
- - 
3 
(3.13%) 
- 19 
Pus 
 
12 
(12.50%) 
 
1 
(1.04%) 
1 
(1.04%) 
- 4 (4.17%) 18 
Total 
 
76 
(79.17%) 
 
5 
(5.21%) 
 
3 
(3.13%) 
 
3 
(3.13%) 
 
9  
(9.38%) 
96 
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 Thus it is inferred that Staphylococcus epidermidis was the most 
common CoNS species isolated from specimens more commonly in 
wound swabs followed by blood, urine and pus specimens.  
  
 All the 96 CoNS isolates were subjected to Biofilm detection by 
various phenotypic methods such as Congo red agar, Tube method, 
Tissue culture plate method. By Congo red agar method only 7 isolates 
showed black colonies with crystalline appearance, 10 isolates showed 
black colonies but no dry crystalline morphology and 79 isolates 
displayed pink colored colonies. By Tube method, the number of strong 
biofilm producers were 12, moderate were 17 and weak or non-biofilm 
producers were 67. In Tissue culture plate method, strong biofilm 
producers were 17, 21 were moderate biofilm producers and 58 
considered as weak or none biofilm producers. 
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Table – 5 
SCREENING OF THE CoNS ISOLATES FOR BIOFILM 
PRODUCTION   BY  PHENOTYPIC  METHODS 
n=96 
No. of CoNS 
isolates (96) 
Biofilm 
production 
Tissue 
Culture 
plate 
(TCP) 
Tube 
method     
(TM) 
Congo red 
agar(CRA)
No. of biofilm 
producers 
High 17(17.70%) 12(12.5%) 7(7.29%) 
Moderate 21(21.87%) 17(17.71%) 10(10.41%) 
Total 38(39.58%) 29(30.21%) 17(17.71%) 
No. of non biofilm 
producers Weak/None 58(60.42%) 67(69.79%) 79(82.29%) 
 
 From the above table, it is observed that the number of biofilm 
producer detected by tissue culture plate method was high 38 
(39.58%),  followed by Tube method and Congo red agar method. 
 
 Among the 38 biofilm producing CoNS isolates, sample wise 
analysis of Biofilm production showed that 16 out of 31 CoNS isolates 
were detected as Biofilm producer from wound swab specimens, 11 out 
of 28 from blood, 9 out of 19 from urine,  2 out of 18 CoNS isolates from 
pus specimen were identified as Biofilm producer 
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Table - 6 
SAMPLE WISE ISOLATION OF BIOFILM PRODUCING CoNS 
n=96                    
Specimen 
No. of Cons 
isolates 
No. of Biofilm 
producers 
Percentage 
Wound swab 31 16 16.67% 
Blood 28 11 11.46% 
Urine  19 9 9.37% 
Pus  18 2 2.08% 
Total 96 38 39.58% 
 
 From the above table it is inferred that the percentage of biofilm 
producing CoNS isolated from wound swab sample was high followed 
by blood, urine and pus specimens. 
 
 Out of 38 biofilm producing CoNS isolates, 37 were 
Staphylococcus epidermidis, 1 was Staphylococcus saprophyticus . 
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Table-7 
SPECIES AND SPECIMEN WISE DISTRIBUTION OF                                  
BIOFILM PRODUCING CoNS     
     n=96 
Specimen 
Staphylococcus 
Epidermidis 
Staphylococcus 
Saprophyticus 
Total 
Wound swab 16 
(16.67%) 
 
- 
16 
Blood 11 
(11.46%) 
 
- 
11 
Urine  8 
(8.33%) 
1 
(1.04%) 
9 
Pus 2 
(2.08%) 
 
- 
2 
Total 37 
(38.54%) 
1 
(1.04%) 
38 
 
 From the above table it is inferred that Staphylococcus 
epidermidis was the most common biofilm producing CoNS species 
and more number of Biofilm producers were isolated from wound 
swab specimen followed by blood, urine and pus specimens. 
 
 Analysis of agewise distribution of biofilm producing CoNS 
showed that among the biofilm producing CoNS isolates 7(18.42%) were  
from the age group  0 -14yrs,  9(23.68%) from the age group of 15-45 
yrs, 10 (26.32%) from the age group of 46-60 yrs and 12 (31.58%) from 
the age group of  >50yrs. 
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Table – 8 
AGE WISE DISTRIBUTION OF BIOFILM PRODUCING CoNS 
n=38 
Age group 
No. of Biofilm 
producer 
Percentage 
0-14 7 18.42% 
15-45 9 23.68% 
46-60 10 26.32% 
>60 12 31.58% 
      
 From the above table it is inferred that the percentage of Biofilm 
producing CoNS isolated from the age group of  >60yrs was the highest 
followed by46-60 yrs of age.  
 
 Among the 38 Biofilm producing CoNS isolates, 29(76.32%) were 
associated with risk factors. Analysis of  Biofilm production with risk 
factors showed  that 15 patients had orthopaedic implants which were 
infected, 8 patients had urinary catheterization, 6 patients had history of 
prosthetic valve implantation. 
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Table-9 
PERCENTAGE OF BIOFILM PRODUCING CoNS ASSOCIATED 
WITH RISK FACTORS 
n=29 
Risk factors No.of Biofilm producer Percentage 
Infected Orthopaedic implants 15 39.47% 
Urinary catheterization 8 21.05% 
Prosthetic valve 6 15.79% 
   
 From the above table it is found that Biofilm production had a 
strong association with medical device related infections such as 
infected orthopaedic implants, urinary catheterization and prosthetic 
valve. 
 
 All the 96 CoNS isolates (Biofilm and non biofilm producers) were 
subjected to antibiotic susceptibility testing by Kirby Bauer disc diffusion 
method.   
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Table-10  
ANTIBIOGRAM OF BIOFILM PRODUCING AND NON 
BIOFILM PRODUCING CoNS ISOLATES 
 
Antibiotics 
Biofilm producers 
(38) 
Non biofilm producers 
(58) 
Sensitive Resistant Sensitive Resistant 
Ampicillin   3(7.89%) 35(92.11%)   8(13.79%) 50(86.21%) 
Gentamicin  20(52.63%`) 18(47.37%) 36(62.06%) 22(37.93%) 
Ciprofloxacin  12(31.58%) 26(68.42%) 39(67.24%) 19(32.75%) 
Cefotaxime  23(60.53%) 15(39.47%) 45(77.59%) 13(22.41%) 
Chloramphenicol 15(39.47%) 23(60.52%) 38(65.51%) 20(34.48%) 
Cotrimoxazole  14(36.84%) 24(63.15%) 41(70.69%) 17(29.31%) 
Erythromycin  22(57.89%) 16(42.11%) 43(74.13%) 15(25.86%) 
Doxycycline  21(55.26%) 17(44.73%) 42(72.41%) 16(27.59%) 
 
 From the above table it is observed that Biofilm producers 
showed higher antibiotic resistance than non biofilm producers. 
Among the Biofilm producer  highest antibiotic resistance were noted 
against Ampicillin followed by Ciprofloxacin, Cotrimoxazole, 
Chloramphenicol, Gentamicin, Doxycycline, Erythromycin and 
Cefotaxime. 
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 PCR was done to identify ica gene in CoNS isolates which were 
found to be biofilm producers by phenotypic methods. Among the 35 
PCR positive Biofilm producing CoNS isolates, TM identified 6 isolates, 
CRA 18 isolates as false negative and none of the isolate was identified 
as false negative by TCP. Among the PCR negative isolates, TCP method 
identified 3 isolates as falsely positive .The false positive identified by 
TM and CRA were 5 and 7 respectively. 
 
Table -11 
COMPARISON OF PCR WITH OTHER  
PHENOTYPIC METHODS 
 
Methods 
True 
positives 
False 
negatives 
False 
positives 
PCR 35 - - 
TCP 35 - 3 
TM 24 6 5 
CRA 10 18 7 
 
 From the above table  it was found that Tisssue culture plate 
method showed only three false positives and thus very close to PCR 
in identifying True positives. 
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Table-12 
SENSITIVITY AND SPECIFICITY OF VARIOUS  
PHENOTYPIC METHODS 
 
Methods Sensitivity Specificity PPV NPV 
TCP 100% 95.08% 92.1% 100% 
TM 80% 92.42% 82.75% 97.04% 
CRA 35.71% 89.71% 58.82% 77.22% 
 
 From the above observation it was found that Tissue culture plate 
method had the highest sensitivity and specificity, the PPV and NPV 
were 92.1% and 100% respectively. TM showed  80% sensitivity and  
92.42% specificity with 82.75%  PPV and 97.04% NPV. CRA method 
had the least sensitivity (35.71%) and specificity (89.71%) with PPV and 
NPV of  58.82% and 77.22%. 
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DISCUSSION 
 
              CoNS have been major cause of nosocomial infections in tertiary 
health care  settings.[132] Since 1950, these organisms have been reported 
with increasing frequency. Taking into consideration, the increased 
frequency of isolation of CoNS from clinical specimens, they must be 
individually evaluated as potentially true pathogens.[119]   The major 
virulence factor determining the pathogenicity of CoNS has now well 
defined and found to be Biofilm production. Biofilm producing bacteria 
are responsible for many recalcitrant infections and are notoriously 
difficult to eradicate. In this study we evaluated 96 CoNS isolates by 
Phenotypic and Genotypic  methods for their ability to form biofilms. 
 
 In the present study, out of 456 samples processed, 252 (55.26%) 
were Staphylococcal species. Among the 252 Staphylococcal species, 
96(38.1%) were Coagulase negative Staphylococci (CoNS). The results 
were correlated with the study conducted by Mahajan VM et al [124] who 
documented that out of 145 Gram positive, catalase positive isolates, 
88(60.6%) isolates were Coagulase negative Staphylococci. However, 
Fule RP et al[119] reported that only 39(23.6%) isolates of CoNS and 165  
of Coagulase positive Staphylococci from various clinical specimens. 
Nearly 1/3rd of CoNS were isolated among the Staphylococcal species 
from various clinical specimen in the above studies. CoNS were generally 
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considered as saprophytes with little pathogenic potential. Over the past 
four decades, however these organisms have become recognized as 
important agents of human disease.[13] .CoNS are pathogenic when 
alterations in the integument allow these normal skin inhabitants to gain 
entry into the body.[128] 
 
 The present study showed that CoNS was isolated more 
31(32.29%) from wound swab specimen collected from infected joint 
prostheses and surgical site infections. The same were reported by Sewell 
CM et al,[128]  in that majority of CoNS isolates (43%) were from 
exudates, Gaikwad SS and Deodhar LP et al,[126] documented that 
drainage from wound was the frequent source of CoNS 40(76.92%). 
However Narayani TV et al [127]  had reported majority of CoNS isolates 
from urine specimen(52%) will counter this current study. CoNS has 
been isolated and documented as a pathogen in infections of various 
prosthetic devices, surgical wound infections, urinary tract infections, 
septicaemia etc. CoNS are opportunistic pathogens that cause infection in 
debilitated patients often by colonizing biomedical devices such as 
prostheses, implants and intravascular lines.[125] CoNS produce cell-
surface and extracellular macromolecules that initiate and subsequently 
enhance bacterial adhesion to the plastic surfaces of foreign bodies to 
form biofilms. [13] Biofilm drastically affects the human cellular  immune 
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response by its affect on the lymphoproliferative response to 
mononuclear cells to polyclonal stimulators. This inhibition of cellular 
response may contribute to  infection of implanted prostheses.[139]  
 
 In this study, Staphylococcus epidermidis was the most commonly 
isolated species 76(79.17%) and isolated in more from wound swab 
26(27.08%) specimens. The second most common isolate was 
S.hemolyticus followed by S.lugdunensis and S.saprophyticus. The 
species predominance was also reported by  Mohan et al [116] who 
documented in their study that S. epidermidis was the most commonly 
isolated species 82.3% (158/192)  and 94%  isolated from pus sample and 
also Marsik et al [117] reported that 72.41% of bacteremia’s caused by S. 
epidermidis and most commonly isolated from bone, joint and wound 
infections, S.hemolyticus (7.47%) was the second most common isolate 
from wound infections and S.saprophyticus (6.41%) was most commonly 
isolated from urinary tract infection. Gaikwad SS and Deodhar LP et 
al,[126] Seetha et al. [125] also documented that  S. epidermidis was the 
predominant isolates among CoNS species. The formation of 
multilayered biofilm appears to  be essential for the pathogenesis of 
device related S.epidermidis infections. The other virulence factors such 
as phosphatase, gelatinase, hemolysins, lipases, proteases also contributes 
to its pathogenicity. S.saprophyticus is a well documented urinary 
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pathogen and uroepithelial tissue tropism and production of urease 
contributes to its pathogenicity.[13] 
 
 The present study showed that 38(39.58%) of CoNS isolates were 
biofilm producers. This finding correlated with studies conducted by 
Seetha et al,[125] Mohan et al,[116] . Makhija SK et al [121] who showed 
that 43(42.5%) CoNS isolates were slime producers. However                    
Pal N et al[129] reported 100% slime production by CoNS. The factor 
determining the pathogenicity of CoNS was found to be extracellular 
slime.[121] Biofilm appears to act as a barrier protecting bacteria from host 
defense mechanisms while providing a suitable environment for bacteria 
survival.[101] A significant association between the ability of  an isolate to 
produce biofilm and its propensity to cause disease has been found in 
other studies also.[129] 
 
Afreenish et al [37] and Donlan et al[130]in their study found that the 
majority of biofilm producing organisms were from urinary catheter tips 
(26.3%). But in the present study, majority of Biofilm producers were 
isolated from wound swab sample (16.67%) collected from infected joint 
prostheses. The inherent capacity of this organism to cause infection in 
device related infections is the ability to form mucoid biofilms on the 
inert synthetic  surfaces of indwelling medical devices.[7] 
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 In this study, Staphylococcus epidermidis 37 (38.54%) was the 
most common Biofilm producing CoNS species followed by 
Staphylococcus saprophyticus 1(1.04%).The same findings were also 
noted in the study conducted by Mohan et al, [116] who documented that 
77 (48.7%)isolates of S.epidermidis and 8(26.7%) isolates of     
S.saprophyticus were Biofilm producers.  Sujata et al [120] reported that 
47.5% of Staphylococcus epidermidis were slime producers.              
Aricola et al [51] noted that 48.5% of their clinical isolates of 
Staphylococcus epidermidis were slime positive. The emergence of  
Staphylococcus epidermidis as a pathogen has been increased with the 
widespread use of indwelling medical devices  and intravascular catheters 
in modern medicine. The ability of the organism to adhere and form 
biofilm on the surface of biomaterials is thought to be the most significant 
virulence factor. 
 
In the present study, the percentage of Biofilm producing CoNS 
isolated from the age group of >60yrs was the highest followed by  46-60 
yr of age. More incidence in higher age group may be due to the 
increasing use of indwelling medical devices which will augment the 
biofilm producing strains of CoNS. Due to high rate of invasive 
procedures in immunocompromised patients and also the bacterium’s 
ability to form biofilms there is increased occurence of these infections .  
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 In the current study, Biofilm production had a strong association 
with medical device related infections (76.32%) such as infected 
implants, urinary catheterization and prosthetic valve. This in correlation  
with study by  Sujata et al [120]  Who had documented that out of 55 
S.epidermidis isolates from various device related infections, 26 (65.2%) 
were biofilm  producers and S. epidermidis was mainly from patients 
with indwelling catheters as documented by Narmata Kuma[ri et al .[123] 
Donlan et al  [91], Raad et al.[97]The use of synthetic material for 
implantation is widely associated with “Implant associated infection” due 
to biofilm production.[98] Biofilm producing Staphylococci easily gets 
attached to polymer surfaces and frequently colonize catheters and 
medical devices causing foreign body related infections. [93],[94],[95] 
 
 In the present study, it was observed that there was higher 
antibiotic resistance in Biofilm producing CoNS isolates than non-
Biofilm producers. This in correlation with  Afreenish Hassan et al [37]  
de Silva et al[131] who observed higher antibiotic resistance in biofilm 
producing bacteria than non-biofilm producers. Sujata et al [120] reported 
in their study that among the 55 implant associated S. epidermidis 
isolates, 23(41.8%) were multidrug resistance strains and 26(65.2%) were 
slime producers. Kim L. Riddle et al [35]   had documented that biofilm 
producing organism exhibit resistance to antibiotics by various methods 
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like restricted penetration of antibiotic into biofilms, decreased growth 
rate and expression of resistance genes. 
  
 In the present study, the percentage of biofilm production detected 
by Tissue culture plate method (39.58%)  was high followed by Tube 
method (30.21%) and Congo red agar method (17.71%). This finding 
correlated with Mathur et al [122] showed that the number of biofilm 
producers identified by TCP method was high (53.9 %) and followed by 
Tube method(11.8% ) and CRA (5.17%). In another study,  conducted by 
Ruzicka et al  [43] noted that out of 147 isolates of S. epidermidis, TM 
detected biofilm formation in 79 (53.7%) and CRA detected in 64 
(43.5%) isolates and reported that TM is better for biofilm detection than 
CRA. Afreenish et al [37] documented in their study that the number of 
isolates showing biofilm formation by TCP was 70 (64.7%), and non or 
weak biofilm producers were 40 (36.3%) and Tube method detected 49% 
isolates as biofilm producers. However, Baqai et al [44]  reported that 
75% of the isolates exhibited biofilm formation by TM. The tube test 
correlates well with the TCP test for strongly biofilm producing isolates 
but it was difficult to discriminated between weak and biofilm negative 
isolates due to the variability in observed results by different observers. 
Consequently, high variability was observed and classification in biofilm 
positive and negative was difficult by tube method. In congo red agar 
68 
 
method out of 17 positive isolates only 7 showed black colonies with dry 
crystalline consistency and remaining isolates showed no correlation with 
TCP and TM.In agreement with the previous reports and  based on our 
results TM and CRA cannot be recommended as general screening test to 
identify biofilm producing isolate.[122] 
  
 In this study, out of 38 Biofilm producing CoNS isolates detected 
by phenotypic method, ica gene was identified by PCR in 35 (36.45%) 
isolates. The results were concordance with the study by Sujata et al [120] 
who had reported in their study that ica gene was present in 23(41.8%) 
among 26(47.2%) of Biofilm producers. The results were in discordance 
with the study by Seung- Hak- Cho  et al [23]  who had reported that 18  
S. epidermidis isolates obtained from catheter-related urinary tract 
infections showed the ica speficic DNA and only 11isolates biofilms 
spontaneously under normal growth conditions  and Galdbart, J. O.,et al 
[50] in their study showed that 44 out  of 54  S. epidermidis  isolates from 
prosthetic-material related joint infection showed ica positivity. Gad et al  
[99] , Cafiso et al  [100] demonstrated  the detection of ica operon by 
molecular technique (PCR)  with high efficiency. In addition, these genes 
are important virulence markers of clinical CoNS isolate since their 
expression is associated with the production of PIA, the most clearly 
characterized component of Staphylococcal biofilms. 
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 The present study showed that ica gene was present in 35 (36.45%) 
of CoNS isolates which were detected as Biofilm producers by Tissue 
culture plate and  sensitivity and specificity of Biofilm detection by  this 
method was  high in comparison with Tube method and Congo red agar. 
TCP can be recommended as a general screening test for biofilm 
production than CRA and TM .Though PCR detects ica genes, the 
virulence marker of staphylococcal infection and Biofilm non-producers 
are negative for icaA and icaD and lack the entire ica ADBC operon. But 
in a developing country like ours, a low cost method for detection of 
biofilm is needed which require inexpensive equipment and less technical 
expertise. 
 
 To compare PCR with TCP, the test share the specific 
identification rates. Although the genotypic methods will be absolute 
detection methods, it was not done in all centres. Considering the cost and 
specialized man power and sophisticated infrastructure, TCP can be 
performed to detect the Biofilm producing strains of CoNS with same 
sensitivity and specificity coinciding with genotypic methods.  
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SUMMARY 
 
• A total of 456 samples were collected to study Biofilm production 
in Coagulase negative Staphylococci. 
 
• Among the 456 clinical samples, 252 were Staphylococcal species. 
Out of 252 Staphylococcal species, 108 had been grossly isolated 
from wound swab specimen. 
 
• Out of 252 Staphylococci isolates, 96 were Coagulase negative 
Staphylococci, which were identified by Coagulase test. 
 
• Wound swab had the highest percentage (32.29%) in respect with 
Coagulase negative Staphylococci isolation among various clinical 
samples. Coagulase negative Staphylococci had been isolated from 
blood, pus, urine samples in greatest way when compared with 
routine isolation of Staphylococci. 
 
• The most common Coagulase negative Staphylococci species were 
Staphylococcus epidermidis followed by Staphylococcus 
haemolyticus, Staphylococcus lugdunensis, and Staphylococcus 
saprophyticus. Staphylococcus epidermidis had the highest 
isolation in wound swab specimen. 
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• Phenotypic detection of  Biofilm production among CoNS isolates 
were high in tissue culture plate, when compared with other 
phenotypic methods such as Tube method and Congo red agar 
method. 
 
• The Biofilm producing CoNS isolates showed higher antibiotic 
resistance than non biofilm producers.  Among the Biofilm 
producer  highest antibiotic resistance were noted against 
Ampicillin followed by Ciprofloxacin, Cotrimoxazole, 
Chloramphenicol, Gentamicin, Doxycycline, Erythromycin and 
Cefotaxime. 
 
• Biofilm production had a strong association with medical device 
related to orthopaedic implants followed by urinary catheterization 
and prosthetic valve. 
 
• Among the phenotypic method, Tissue culture plate had the highest 
sensitivity and specificity as compared with genotypic method. 
 
• Though genotypic method had the absolute value in detection of 
Biofilm production in an infectious agent, the Tissue culture plate 
can be recommended for the identification of Biofilm producing 
organism due to cost effectiveness, short turn around time and 
capability of being used in  routine diagnostics. 
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CONCLUSION 
 
• Coagulase negative Staphylococci are responsible for nosocomial 
infections at GRH, Madurai and Staphylococcus epidermidis is the 
most commonly isolated CoNS species. 
 
• Resistance among CoNS are increasing especially among the 
patients with the indwelling medical  devices due to Biofilm 
production. 
 
• As infection caused by Biofilm producing bacteria are difficult to 
treat, early diagnosis and management is necessary to reduce 
morbidity and mortality. 
 
• This study was focused on finding out of a simple, economic and 
more accessible method with high sensitivity and specificity to 
identify Biofilm production. 
 
• Various phenotypic methods were compared with PCR and found 
that Tissue culture plate method showed high sensitivity and 
specificity and it is closer to PCR. 
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• Tissue culture plate method was proved to be simple, economical 
method can be recommended for early and prompt diagnosis of 
Biofilm production. 
 
• Prophylactic antibiotic therapy to cover surgical insertion of most 
biomaterials and this will help in slightly slow progression of 
biofilms in biomaterials. Catheters should be inserted with 
meticulous attention to aseptic practices. Staff should adhere to 
appropriate aseptic protocols in caring out the indwelling 
catheterization. 
 
 The clinical significance of CoNS is increasing day by day in 
device related infections, urinary tract infections, endocarditis. Very soon 
CoNS may emerge as one of the leading nosocomial pathogen. 
Staphylococcus epidermidis can cause a number of human infections and 
should no longer be considered as a harmless commensal. The virulence 
of CoNS is directly related to its capability to establish multilayered, 
highly structured biofilms on artificial surfaces. There is association 
between biofilm production with persistent infection and antibiotic 
failure. Hence, in small microbiological laboratories where PCR cannot 
be done, Tissue culture plate method can be recommended which is 
simple and cost effective. 
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ANNEXURE -1  
PREPARATION OF GRAM STAIN 
GRAM STAIN REAGENTS 
 
1. Methyl violet – Primary stain 
    Methyl violet 10g 
    95% Ethyl alcohol 100ml 
    Distilled water 1 L 
 
2. Gram’s Iodine – Mordant 
    Iodine 10g  
    Potassium Iodide 20 g 
    Distilled water 1 L 
 
3. Acetone – Decolouriser 
 
4. Dilute carbol fuchsin – Counter stain 
   Basic fuchsin 0.3g 
   95% Ethyl alcohol 10ml 
   Phenol crystals,melted 5ml 
   Distilled water 95ml  
 
Dissolve fuchsin in alcohol. Add the 5% phenol solution. Allow it to 
stand overnight. Filter through coarse filter paper. 
 
 
 
 ANNEXURE – 2 
PREPARATION OF MEDIA 
 
 
CONGO RED AGAR PLATE :  To prepare 1L of CRA medium 
1.Brain heart infusion broth  37 g/L 
2. Sucrose 50 g/L  
3. Agar No.1 10 g/L and  
4. Congo Red indicator 8 g/L.  
 
 First Congo Red stain was prepared as a concentrated aqueous 
solution and autoclaved (121oC for 15 minutes) separately from the other 
medium constituents. Then it, was added to the autoclaved brain heart 
infusion agar with sucrose at 55oC. 
 
 
 
 
 
 
 
 
ANNEXURE – 3 
PROFORMA 
 
1. CASE NO. :  
2. NAME : 
3. AGE : 
4. SEX : 
5. ADDRESS : 
6. IP/OP NO : 
7. UNIT/WARD : 
8. SPECIMEN : 
9. DATE OF SAMPLE COLLECTION : 
10. BRIEF CLINICAL HISTORY : 
11. CLINICAL DIAGNOSIS :  
12. TREATMENT HISTORY : 
13. GENERAL PHYSICAL EXAMINATION: 
 
MICROBIOLOGICAL INVESTIGATIONS: 
1. DIRECT SMEAR STUDY :        PUS CELLS:  
        (GRAM’S STAIN)                 EPITHELIAL CELLS: 
                                                    BACTERIAL MORPHOLOGY: 
 
 
 
2. GROWTH ON CULTURE MEDIA: 
        a. NUTRIENT AGAR PLATE: 
        b. MAC CONKEY AGAR PLATE: 
        c. BLOOD AGAR PLATE: 
 
3. CULTURE SMEAR: 
        (GRAM’S STAIN) 
 
4. CATALASE TEST:       
  
5. OXIDASE TEST:        
       
6. COAGULASE TEST: 
 
SPECIATION 
7. PHOSPHATASE TEST 
 
8. ORNITHINE DECARBOAXYLASE TEST 
 
9. NOVOBIOCIN SENSITIVITY TEST: 
 
10. ANTIBIOTIC SENSITIVITY 
AMP C CIP CTX GM COT ERM DOX 
S R S R S R S R S R S R S R S R 
                
 
 
BIOFILM DETECTION: 
BIOFILM 
PRODUCTION 
TISSUE 
CULTURE   
PLATE 
TUBE 
METHOD 
CONGO 
RED 
AGAR 
PCR 
ica gene 
High     
Moderate     
Weak/None     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 

 
S. 
NO 
 
NAME AGE SEX IP/OP NO 
WAR
D 
/UNIT 
SPECIMEN DIAGNOSIS ORGANISM ISOLATED 
ANTIBIOGRAM BIOFILM    DETECTION 
AMP C CIP CTX GM 
CO
T ERM DOX 
T
C
P 
T
M 
C
R
A 
P
C
R
1. Pandiyammal 64 F 36253 O – IV Wound swab Infected 
implant 
S.epidermidis R S R R S S S S + + + +
2. Radha 46 F 37267 S  -1 Pus  Abscess S.epidermidis R S R S R R S R + + + +
3. B/o Janaki 1/365 M 37289 I PU Blood  Neonatal 
septicaemia 
S.epidermidis R S S S S R R R - + - - 
4. Lakshmi 51 F 28882 S -3 Wound swab Ulcer S.epidermidis S S S R S R S R - - + - 
5. Muthulaxmi 47 F 41117 S -5 Wound swab Surgical site 
infection 
S.hemolyticus R R S S S S S S - - - - 
6. Mahalingam 35 M 38804 M -6 Blood  IE S.epidermidis R R R S R R R R + + + +
7. Venkatadharn 46 M 38307 S -4 Pus Abscess S.epidermidis R S S R S R R R - + - - 
8. Poomari 63 F 33415 M-3 Urine UTI S.saprophyticus R R S S S S R R + - - - 
9 Kathiresan 13 M 38916 M -1 Blood  PUO S.epidermidis S R R S R R R R + - - +
10. Vanishree 8 F 24869 O-III Wound swab Infected 
implant 
S.epidermidis R S S S S R R R + + - +
11. Vallimuthu 21 M 34129 M-7 Blood PUO S.epidermidis S S S R R S R R - - + - 
12. Santhi 57 F 31589 S-3 Pus Abscess S.epidermidis R R S S S S S S - - - - 
13 Indira 11 F 36952 S-7 Wound swab Surgical site 
infection 
S.epidermidis R S R S S R S S + + - +
14 Vijayajaeyanthi 38 F 34652 M-3 Urine UTI S.epidermidis R R S S R S S S - - - - 
15 Rani 62 F 40785 O- II Wound swab Infected 
implant 
S.epidermidis R R S S S S S R + - - +
16 Subramani 61 M 42468 M-1 Urine UTI S.epidermidis S R R S S R R S + + + +
17 Kalimuthu 63 M 42249 O-I Wound swab Osteomyelitis S.hemolyticus R S S S S R S S - - - - 
18 Mookammal 32 F 24750 S-5 Pus Stricture 
abscess 
S.epidermidis S R S S R S S S - - - - 
19 Rupa 13 F 42991 M-4 Blood  PUO S.epidermidis R S S R S R R R - - - - 
20 Muthukumar 31 M 37812 S-1 Wound swab Ulcer S.epidermidis R S S S S R S S - - - - 
21 Vimala 48 F 42821 M-2 Urine UTI S.epidermidis R R S S R R R S + - - +
22 Sankarammal 64 F 42916 S-5 Pus Abscess S.epidermidis R S S S S R S S - - - - 
23 Madhavi 25 F 25220
5 
M-3 Blood PUO S.epidermidis S S S R R S R R - - - - 
24 Pitchaimuthu 65 M 40926 O- I Wound swab Infected 
implant 
S.epidermidis R R S S R R S R + + - +
25 Swetha 14 F 36455 O-IV Wound swab Infected 
implant 
S.epidermidis R R S S R S R S + + - +
26 Murugesan 47 M 34729 M-5 Blood PUO S.epidermidis R R S S S R S S - - + - 
27 Sundarammal 32 F 73512 S-4 Wound swab Surgical site 
infection 
S.epidermidis R R S S R S R R - - - - 
28 Periakaruppu 48 M 17711 S-6 Pus Abscess S.epidermidis R R S S S R S S - - - - 
29 Veluthayi 44 F 41410 M-1 Blood IE S.epidermidis R S R R S R R S + + + +
30 Angaleeswari 29 F 39722 M-5 Blood PUO S.hemolyticus R S S S S R S S - - - - 
MASTER CHART 
31 Ponnaiyan 47 M 44348 S-3 Wound swab Ulcer S.lugdunensis R R S S S S S S - - - - 
32 Chinnakalai 51 M 53223 S-6 Wound swab Surgical site 
infection 
S.epidermidis S R S S S S R R - - - - 
33 Esaikiraja 60 M 42171 PSW Wound swab Wound 
infection 
S.epidermidis R S S S S S S S - - - - 
34 Perumal 65 M 41679 NSW Pus Cerebral 
abscess 
S.epidermidis S R S S S R S S + + - +
35 Nathiya 11 F 34592 IV PU Blood Septicemia S.epidermidis R R R R R R R R - - +  
36 Kothaiammal 36 F 20659 S-1 Pus Abscess S.epidermidis R S S S S R S S - - - - 
37 Kannan 64 M 44950 M-6 Urine UTI S.epidermidis R R S S S R S R + - - - 
38 Udhayan 38 M 41191 S-1 Pus Abscess S.epidermidis S R S R R R R R - - - - 
39 Poongodi 33 F 41538 M-2 Blood PUO S.epidermidis R R R S S S S S - - - - 
40 Thayammal 55 F 45175 M-5 Blood IE S.epidermidis R S S R S R S S + + - +
41 Mangayarkarasi 28 F 40157 M-1 Blood PUO S.epidermidis R R R S S S S S - - - - 
42 Pandi 66 M 35922 O-III Wound swab Infected 
implant 
S.epidermidis R R R S R R S S + + + +
43 Mariyammal 45 F 51912 M-4 Urine UTI S.epidermidis S R S R S S R R - + - - 
44 Ponnusamy 50 M 53851 S-6 Pus Abscess S.epidermidis R R S S S S S S - - - - 
45 Santhosh 9 M 51938 II PU Blood Septicemia S.epidermidis R S R S S S S S - - - - 
46 Selvi 18 F 55934 S-5 Pus Abscess S.epidermidis R R S R S S S S - - - - 
47 Mogana 23 F 55987 M-1 Blood PUO S.epidermidis R R R S S S S S - - - - 
48 Palanisamy 52 M 55956 M-5 Urine UTI S.epidermidis R R S S R R S R + - - - 
49 Dhanam 31 F 56025 O-I Wound swab Infected 
implant 
S.epidermidis R R S S S R R S + - - +
50 Krishnan 61 M 43210 O-1I Wound swab Infected 
implant 
S.epidermidis R S R S S R R R + + + +
51 Geetha 27 F 53486 S-5 Pus Abscess S.hemolyticus R R S S R S S S - - - - 
52 Revathi 35 F 54923 M-6 Blood PUO S.epidermidis R S R S S S S S - - + - 
53 Mallika 13 F 57212 O-1 Wound swab Osteomyelitis S.epidermidis R S S S S R S S - - - - 
54 Muthu 45 M 57277 M-4 Blood PUO S.epidermidis R S R S R S S S - - + - 
55 Nagammal 54 F 52817 S-4 Wound swab Surgical site 
infection 
S.epidermidis R S R S S R S S - - - - 
56 Ramesh 46 M 56915 O-1V Wound swab Infected 
implant 
S.epidermidis R R R R R R S S + + + +
57 Rosammal  41 F 58406 M-5 Blood IE S.epidermidis R R R S S S R R + + - +
58 Siva 16 M 55683 M-2 Blood PUO S.epidermidis R S S S R S S S - - - - 
59 Dhanalakshmi 36 F 59201 S-4 Pus Abscess S.epidermidis R S S S R S S S - + - - 
60 Bhuvaneswari 21 F 56710 M-6 Blood PUO S.epidermidis R S S S R S S S -  - - 
61 Kamali 12 F 41296 I PU Blood PUO S.epidermidis R R R R S S R R + + + +
62 Subbaiah 52 M 55910 O-I Wound swab Infected 
implant 
S.epidermidis R S R R S S S R + - - +
63 Kanimozhi 20 F 58168 M-4 Urine UTI S.saprophyticus R S S S R S S S - - - - 
64 Rajalaxmi 48 F 65514 M-5 Blood IE S.epidermidis R S R R R R S S + + - +
65 Alagarsamy 67 M 72427 M-1 Urine UTI S.epidermidis R R R R S S S R + + - +
66 Chinnapriya 13 F 57432 S-6 Wound swab Cellulitis S.epidermidis R S S S S S S S - - - - 
67 Rajammal 39 F 46877 M-3 Blood IE S.epidermidis R S R S R R S R + - - +
 68 Sakthivel 21 M 83815 S-5 Pus Abscess S.epidermidis R S S S R S S S - - - - 
69 Shanmugavalli 47 F 60345 M-6 Urine UTI S.epidermidis R R R S R S S S + - - +
70 Ponnusamy 52 M 60558 O-II Wound swab Infected 
implant 
S.epidermidis R R R R S R R S + + - +
71 Annarani 31 F 48076 M-6 Urine UTI S.epidermidis R S S S R S S S - - - - 
72 Urkavalan 47 M 59289 S-6 Pus Abscess S.epidermidis R S R S S S S S - - - - 
73 Kanaga 14 F 54949 O-1V Wound swab Infected 
implant 
S.epidermidis R S R R R S S R + + - +
74 Sathish 10 M 53616 II PU Blood PUO S.epidermidis R R R S S R S S + - - +
75 Mohameddusain 9 M 49895 III PU Blood Septicemia S.epidermidis R S R S R S S S - - - - 
76 Tamilselvi 19 F 51298 O-II Wound swab Infected 
implant 
S.epidermidis R R R R S S S S + + - +
77 Rajamani 23 F 56070 M-5 Urine UTI S.saprophyticus R S S S S R R R - - - - 
78 Kotaimuthu 49 M 63797 M-1 Blood PUO S.hemolyticus R R R S S S S S - - - - 
 
79 Tamilrani 49 F 63717 O-II Wound swab Osteomyelitis S.epidermidis R S R S R S S S - + - - 
80 Balu 50 M 57212 M-4 Urine UTI S.epidermidis R R R R R S S R + + + +
81 Rajeswari 34 F 44504 M-6 Urine UTI S.epidermidis R S R S S S S S -   - 
82 Abinaya 8 F 61944 O-II Wound swab Infected 
implant 
S.epidermidis R R S S R R S S + + - +
 
83 Narayanan 7 M 64974 IV PU Blood PUO S.lugdunensis R S S R R S S R - -  - 
84 Periyakaruppan 72 M 58283 M-2 Urine UTI S.epidermidis R R R R S S R R - - + - 
85 Mahalakshmi 47 F 61384 O-I Wound swab Infected 
implant 
S.epidermidis R S R S S S S S - - - - 
86 Kunjaram 31 F 59583 M-6 Urine UTI S.epidermidis R S S S R S S S - -  - 
87 Mariammal 41 F 64778 M-2 Urine UTI S.epidermidis R S R S R S S S - - - - 
88 Kaliraja 14 M 68841 S-6 Pus Abscess S.epidermidis R S R S S S S R - - - - 
89 Velammal 33 F 57212 M-1 Blood PUO S.epidermidis R S R R R S S S + - - +
90 Sowmini 12 F 58834 S-1 Pus Abscesss S.epidermidis R S S S R S S S - - - - 
91 Amaravathy 45 F 69270 0-IV Wound swab Infected 
implant 
S.epidermidis R S R S R R R S + - - +
92 Manikandan 9 M 70722 O-I Wound swab Infected 
implant 
S.epidermidis R S S R R R R S - - - - 
93 Priya 10 F 61753 M-I Blood PUO S.epidermidis R S R S R S R R - - - - 
94 Kaliammal 62 F 64684 M-1 Urine  UTI S.epidermidis R S R R R S R S + + - +
95 Selvam 7 M 63747 S-4 Pus Abscess S.lugdunensis R S R R S S R S - - - - 
96 Balamani 60 F 68195 O-II Wound swab Infected 
implant 
S.epidermidis R S R R S R R S + - - +
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FIGURE 1 
GRAM STAIN SHOWING 
GRAM POSITIVE COCCI IN CLUSTERS 
 
 
FIGURE 2 
NUTRIENT AGAR PLATE SHOWING  WHITE COLOUR 
COLONIES 
 
    
 
 
 
 
FIGURE 3 
MANNITOL AGAR PLATE SHOWING  WHITE COLOUR 
COLONIES 
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CATALASE TEST                                 TUBE COAGULASE 
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              FIGURE  6                                                                 FIGURE 7 
PHOSPHATASE TEST                 ORNITHINE 
  DECARBOXYLASE              
              TEST  
        
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8 
  DISC DIFFUSION TEST – NOVOBIOCIN 
 
               SENSITIVE                                             RESISTANT 
              
 
FIGURE 9 
BLOOD AGAR PLATE SHOWING BETA HEMOLYSIS 
 
 
 
 
 
 
 
FIGURE 10 
ANTIBIOTIC SUSCEPTIBILITY TEST 
 
 
FIGURE 11 
                         CONGO RED AGAR METHOD 
BIOFILM POSITIVE                      BIOFILM NEGATIVE 
     
 
 
 
 
 
 
FIGURE 12 
TUBE METHOD 
                    BIOFILM POSITIVE         NEGATIVE  
              
 
FIGURE 13 
TISSUE CULTURE PLATE METHOD 
 
 
 
 
 
 
 
FIGURE 14 
GEL DOCUMENTATION OF ICA GENE BY PCR 
 
 
 
 
